MarketCap
Facebook
X
TelegramAnnual report 2024
added 12-27-2025
Oncolytics Biotech Historical Prices 2011-2025 | ONCY
Annual Historical Prices Oncolytics Biotech
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.63 | 1 | 2.14 | 1.39 | 2.38 | 4.76 | 1.81 | 5.42 | 2 | 2.56 | 5.04 | 14.7 | 37.2 | 37 |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 37.2 | 0.63 | 8.44 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Aclaris Therapeutics
ACRS
|
1.97 | $ 3.01 | 3.72 % | $ 233 M |  USA |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.2 | 4.41 % | $ 7.7 B |  Australia |
 |
Autolus Therapeutics plc
AUTL
|
1.66 | $ 1.94 | -1.52 % | $ 495 M |  Britain |
 |
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M |  France |
 |
Aptorum Group Limited
APM
|
0.75 | $ 1.08 | -3.15 % | $ 5.89 M |  China |
 |
BioVie
BIVI
|
1.65 | $ 1.14 | 1.04 % | $ 1.68 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Ascendis Pharma A/S
ASND
|
153 | $ 212.5 | 1.52 % | $ 5 B |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | USA |
 |
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | USA |
 |
Athersys
ATHX
|
0.9 | - | 3.77 % | $ 22.4 M | USA |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
0.27 | - | -9.72 % | $ 5.89 M | USA |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M |  Canada |
 |
Can-Fite BioPharma Ltd.
CANF
|
1.45 | $ 0.2 | 6.7 % | $ 435 M |  Israel |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.7 | - | -15.15 % | $ 60.3 M | Britain |
 |
Catalyst Biosciences
CBIO
|
0.51 | $ 11.56 | -0.34 % | $ 761 M | USA |
 |
Berkeley Lights
BLI
|
1.7 | - | -7.31 % | $ 87 M | USA |
 |
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | USA |
 |
BioNTech SE
BNTX
|
95.4 | $ 95.04 | -0.26 % | $ 27.2 B | Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
27 | $ 26.82 | -0.67 % | $ 1.3 B | USA |
 |
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Calithera Biosciences
CALA
|
13.3 | - | -10.95 % | $ 876 K | USA |
 |
Certara
CERT
|
12.4 | $ 8.82 | -0.4 % | $ 1.41 B | USA |
 |
Anika Therapeutics
ANIK
|
25.4 | $ 9.57 | 0.21 % | $ 140 M | USA |
 |
bluebird bio
BLUE
|
0.61 | - | - | $ 546 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
92.9 | - | -6.81 % | $ 3.04 B | USA |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | USA |
 |
Cellectis S.A.
CLLS
|
1.27 | $ 4.8 | 0.34 % | $ 116 M | France |
 |
Axon Enterprise
AXON
|
526 | $ 572.17 | 0.01 % | $ 43.3 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
2.51 | $ 2.57 | 0.78 % | $ 16.1 M | USA |
 |
ChromaDex Corporation
CDXC
|
5.67 | - | -0.88 % | $ 598 M | USA |
 |
AstraZeneca PLC
AZN
|
74.2 | $ 92.14 | -0.4 % | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
2.11 | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
10.6 | $ 8.91 | -1.11 % | $ 1.46 B | Britain |
 |
Celldex Therapeutics
CLDX
|
20.4 | $ 27.28 | 3.22 % | $ 1.76 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
133 | $ 11.63 | -0.09 % | $ 752 M | USA |